DarioHealth Corp. (DRIO)

NASDAQ: DRIO · IEX Real-Time Price · USD
5.77
+0.10 (1.76%)
At close: Feb 7, 2023, 4:00 PM
5.97
+0.20 (3.47%)
After-hours: Feb 7, 2023, 6:30 PM EST
1.76%
Market Cap 148.17M
Revenue (ttm) 26.88M
Net Income (ttm) -73.03M
Shares Out 25.68M
EPS (ttm) -3.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 118,030
Open 5.72
Previous Close 5.67
Day's Range 5.57 - 5.94
52-Week Range 3.53 - 9.31
Beta 1.26
Analysts Buy
Price Target 13.34 (+131.2%)
Earnings Date Mar 28, 2023

About DRIO

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-s... [Read more]

Sector Healthcare
Founded 2011
Employees 200
Stock Exchange NASDAQ
Ticker Symbol DRIO
Full Company Profile

Financial Performance

In 2021, DarioHealth's revenue was $20.51 million, an increase of 170.76% compared to the previous year's $7.58 million. Losses were -$78.77 million, 137.9% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for DRIO stock is "Buy." The 12-month stock price forecast is $13.34, which is an increase of 131.20% from the latest price.

Price Target
$13.34
(131.20% upside)
Analyst Consensus: Buy
Stock Forecasts

News

DarioHealth Announces Preliminary Fourth Quarter and Full Year 2022 Operating Results

Preliminary Results demonstrate success in B2C to B2B transformation Total revenue for the year is expected to be $27.5 million compared to $20.5 million in 2021. B2B expected to represent approximate...

1 day ago - PRNewsWire

Dario Adds New Senior Vice President of Growth to Expanding Sales Team

Matt Alberico joins Dario to help manage expanding growth opportunities after successfully driving customer growth at Amazon Care, Cigna and Aetna NEW YORK , Jan. 24, 2023 /PRNewswire/ -- DarioHealth ...

2 weeks ago - PRNewsWire

Dario Publishes New Research in Peer Reviewed Journal Demonstrating Improved Outcomes by Race and Ethnicity

New York , Jan. 9, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the publication of new re...

1 month ago - PRNewsWire

Dario Achieves Goal of 100 Business-to-Business Contracts in 2022

Northeast supermarket chain will deploy Dario's cardiometabolic suite in 2023 NEW YORK , Jan. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the globa...

1 month ago - PRNewsWire

Leading International Wellness Company Selects Dario as Partner for Musculoskeletal Health Improvement Program

Dario Move to be deployed in Greece and Cyprus to help improve the musculoskeletal health of the general populations New York , Dec. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Com...

1 month ago - PRNewsWire

New Research Published in Peer Reviewed Journal Demonstrating Dario's Musculoskeletal Solution Reduces Back Pain

NEW YORK , Dec. 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced the publication of a new study in the pee...

1 month ago - PRNewsWire

Two New Employers Join Dario Through Benefits Brokerage Partner

The new accounts originated through an existing relationship with a benefits brokerage and provide further validation of Dario's partnership Strategy. NEW YORK , Dec. 1, 2022 /PRNewswire/ -- DarioHeal...

2 months ago - PRNewsWire

Dario to Participate in Craig-Hallum and BTIG Digital Health

NEW YORK , Nov. 16, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at...

2 months ago - PRNewsWire

DarioHealth Reports Third Quarter 2022 Financial and Operating Results

Third quarter 2022 revenues of $6.6 million increased 17.3% from $5.6 million in the third quarter of 2021 driven by growth in Business-to-Business (B2B) revenues. Nine-month year to date revenue tota...

3 months ago - PRNewsWire

DarioHealth to Report Third Quarter 2022 Results on Monday, November 14th

Company to host conference call and webcast at 8:30 am ET the next day NEW YORK , Nov. 9, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) marke...

3 months ago - PRNewsWire

Dario Announces Two Employer Contracts for Full Suite of Digital Health Solutions

New 'jumbo' employer account represents increasing penetration of the Dario platform NEW YORK , Oct. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in t...

3 months ago - PRNewsWire

Dario's Full Suite of Digital Solutions Selected by Midwestern City to Improve Employee Health

Dario to support City employees with integrated solutions addressing diabetes, hypertension, weight management, musculoskeletal and behavioral health in company's first government contract win NEW YOR...

4 months ago - PRNewsWire

DarioHealth Publishes New Clinical Research Linking the Use of its Biofeedback Device to Reduced Back Pain

New research sheds light on the importance of training to drive healthier posture  NEW YORK, Sept. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutic...

4 months ago - PRNewsWire

DarioHealth Announces Two New Employer Contracts

New accounts demonstrate continued demand for integrated and holistic digital chronic condition management solutions NEW YORK , Sept. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Co...

5 months ago - PRNewsWire

DarioHealth Reports Second Quarter 2022 Financial and Operating Results

Q2 revenue of 6.2 million, a 17.5% increase from the $5.3 million of the second quarter of 2021. Six-month year-to-date revenue totaled $14.2 million, a  60.8% increase over the first six months of 20...

6 months ago - PRNewsWire

DarioHealth Presents New Research Demonstrating the Ability to Support People in Rural Areas and Deliver Lasting Health Improvements

The research examines Dario's ability to improve the health of members in rural areas compared to their urban counterparts and found the solution to be equally effective NEW YORK , Aug. 12, 2022 /PRNe...

6 months ago - PRNewsWire

DarioHealth Selected by National Health Plan to Enhance Mental Health and Well-Being for Members

Dario's digital behavioral health solution will help to improve access and navigation across mental health resources NEW YORK , Aug. 11, 2022 /PRNewswire/ -- DarioHealth Corp. ("Dario", "DarioHealth" ...

6 months ago - PRNewsWire

DarioHealth to Report Second Quarter 2022 Results on Monday, August 15

Company to host conference call and webcast at 8:30 am ET NEW YORK , Aug. 10, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today ann...

6 months ago - PRNewsWire

DarioHealth Presents New Research Demonstrating the Impact of a Digital Solution on Depression and Anxiety at the American Psychological Association Annual Convention

The studies underscore the value of Dario's integrated behavioral health solution to help more people connect to effective care that is right for their needs NEW YORK , Aug. 4, 2022 /PRNewswire/ -- Da...

6 months ago - PRNewsWire

DarioHealth Demonstrates Continued Growth in Multi-Chronic Contracts with Latest Addition of a National Employer for the Full Solution Suite

Demand for Dario's single approach to chronic condition management continues to show strong demand NEW YORK , July 21, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global dig...

7 months ago - PRNewsWire

DarioHealth Announces New Contract with a National Employer

Dario continues to grow footprint in the employer market NEW YORK , June 21, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today anno...

8 months ago - PRNewsWire

Solera Health Adds DarioHealth to Its Cardiometabolic Network to Offer Hypertension Management Solutions

The addition of Dario's hypertension solution expands Solera's suite of best-in-class digital and community evidence-based health solutions PHOENIX , June 15, 2022 /PRNewswire/ -- Solera Health, the p...

8 months ago - PRNewsWire

Dario Health (DRIO) Poised To Inflect Upon Full Launch of National Health Plan

Dario Health (DRIO) Poised to Inflect Upon Full Launch of National Health Plan - Fundamentals: Company positioned to avoid dilutive financing after recent $50M credit facility with OrbiMed - Catalysts...

8 months ago - Benzinga

DarioHealth Secures $50 Million Dollar Non-Dilutive Credit Facility with OrbiMed

Investment from Elite Healthcare Fund Provides Validation, Access to Capital and Significant Runway to Execute on Strategic Operating Plan NEW YORK , June 9, 2022 /PRNewswire/ -- DarioHealth Corp. (NA...

8 months ago - PRNewsWire

DarioHealth Presents Three New Studies Demonstrating Improved Health in Users with Multiple Conditions at the American Diabetes Association's 82nd Scientific Sessions

The studies demonstrated significant improvement in glucose control and reductions in blood pressure for users managing diabetes and hypertension and improvement in clinical measures for users with di...

8 months ago - PRNewsWire